Essure news

Essure is a type of permanent birth control device that was approved by the FDA in 2002. However, in recent years, there have been numerous reports of complications and side effects associated with the device, leading to a significant number of lawsuits and a recall of the device in 2018.

Here are some recent news updates on Essure:

• In 2018, the FDA issued a recall of Essure due to reports of serious complications, including perforation of the uterus and fallopian tubes, and migration of the device to other parts of the body.
• In 2019, a study published in the Journal of the American Medical Association found that women who had Essure implanted were more likely to experience complications and side effects compared to women who had other types of birth control.
• In 2020, a jury awarded a woman $1.7 million in damages after finding that Bayer, the manufacturer of Essure, had failed to adequately warn her about the risks associated with the device.
• In 2020, the FDA announced that it would be requiring Bayer to conduct additional testing on Essure to assess the risk of complications and side effects.
• In 2020, a class-action lawsuit was filed against Bayer on behalf of thousands of women who claim to have suffered complications and side effects from Essure.
• In 2021, a study published in the journal Fertility and Sterility found that women who had Essure implanted were more likely to experience depression and anxiety compared to women who had other types of birth control.

It's worth noting that while Essure is no longer available for sale in the United States, it is still available in some other countries. Women who have had Essure implanted are advised to consult with their healthcare provider to discuss their options for removal of the device and to address any complications or side effects they may be experiencing.